Supernus Pharmaceuticals
SUPN
#4328
Rank
NZ$3.41 B
Marketcap
$61.81
Share price
1.12%
Change (1 day)
34.98%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total debt

Total debt on the balance sheet as of September 2024 : NZ$65.1 Million

According to Supernus Pharmaceuticals 's latest financial reports the company's total debt is NZ$65.1 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Supernus Pharmaceuticals - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$65.66 M-90.63%
2022-12-31NZ$0.70 B12.05%
2021-12-31NZ$0.62 B8.87%
2020-12-31NZ$0.57 B2.19%
2019-12-31NZ$0.56 B14.4%
2018-12-31NZ$0.49 B
2017-12-31N/A-100%
2016-12-31NZ$6.01 M-41.92%
2015-12-31NZ$10.35 M-69.07%
2014-12-31NZ$33.46 M-20.03%
2013-12-31NZ$41.85 M50.37%
2012-12-31NZ$27.83 M-26.33%
2011-12-31NZ$37.78 M-61.14%
2010-12-31NZ$97.21 M-5.85%
2009-12-31NZ$0.10 B-20.1%
2008-12-31NZ$0.12 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.68 B 948.41%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$53.10 B 81,465.54%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$87.70 B 134,620.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$25.56 B 39,160.35%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$61.00 B 93,604.30%๐Ÿ‡บ๐Ÿ‡ธ USA